DarioHealth Statistics
Share Statistics
DarioHealth has 44.45M
shares outstanding. The number of shares has increased by 38.91%
in one year.
| Shares Outstanding | 44.45M |
| Shares Change (YoY) | 38.91% |
| Shares Change (QoQ) | 8.86% |
| Owned by Institutions (%) | 19.19% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 25,352 |
| FTD / Avg. Volume | 10.54% |
Short Selling Information
The latest short interest is 2.87M, so 6.54% of the outstanding
shares have been sold short.
| Short Interest | 2.87M |
| Short % of Shares Out | 6.54% |
| Short % of Float | 7.16% |
| Short Ratio (days to cover) | 14.59 |
Valuation Ratios
The PE ratio is -1.24 and the forward
PE ratio is -1.43.
DarioHealth's PEG ratio is
0.02.
| PE Ratio | -1.24 |
| Forward PE | -1.43 |
| PS Ratio | 1.95 |
| Forward PS | 0.5 |
| PB Ratio | 0.73 |
| P/FCF Ratio | -1.36 |
| PEG Ratio | 0.02 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for DarioHealth.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.44,
with a Debt / Equity ratio of 0.42.
| Current Ratio | 2.44 |
| Quick Ratio | 2.15 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | -0.6 |
| Debt / FCF | -0.78 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $137,959.18 |
| Profits Per Employee | $-218,096.94 |
| Employee Count | 196 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 2.9 |
Taxes
| Income Tax | -1.85M |
| Effective Tax Rate | 4.15% |
Stock Price Statistics
The stock price has increased by -49.65% in the
last 52 weeks. The beta is 1.56, so DarioHealth's
price volatility has been higher than the market average.
| Beta | 1.56 |
| 52-Week Price Change | -49.65% |
| 50-Day Moving Average | 0.69 |
| 200-Day Moving Average | 0.79 |
| Relative Strength Index (RSI) | 52.55 |
| Average Volume (20 Days) | 240,554 |
Income Statement
In the last 12 months, DarioHealth had revenue of 27.04M
and earned -42.75M
in profits. Earnings per share was -0.61.
| Revenue | 27.04M |
| Gross Profit | 13.27M |
| Operating Income | -57.74M |
| Net Income | -42.75M |
| EBITDA | -50.32M |
| EBIT | -57.74M |
| Earnings Per Share (EPS) | -0.61 |
Full Income StatementBalance Sheet
The company has 27.76M in cash and 30.19M in
debt, giving a net cash position of -2.43M.
| Cash & Cash Equivalents | 27.76M |
| Total Debt | 30.19M |
| Net Cash | -2.43M |
| Retained Earnings | -390.34M |
| Total Assets | 118.88M |
| Working Capital | 23.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -38.56M
and capital expenditures -138K, giving a free cash flow of -38.7M.
| Operating Cash Flow | -38.56M |
| Capital Expenditures | -138K |
| Free Cash Flow | -38.7M |
| FCF Per Share | -0.58 |
Full Cash Flow StatementMargins
Gross margin is 49.06%, with operating and profit margins of -213.55% and -158.09%.
| Gross Margin | 49.06% |
| Operating Margin | -213.55% |
| Pretax Margin | -164.94% |
| Profit Margin | -158.09% |
| EBITDA Margin | -186.08% |
| EBIT Margin | -213.55% |
| FCF Margin | -143.12% |
